Home » Topics » BioWorld Science

BioWorld Science
RSS

Harbour BioMed and AstraZeneca enter global outlicense agreement for HBM-7022

April 7, 2022

HitGen and Uppthera extend their PROTAC collaboration

April 7, 2022

Alternate approach could enable earlier detection, intervention, in Alzheimer's

April 7, 2022

Discovery of noncovalent peptidomimetic proteasome inhibitors for the treatment of MM

April 7, 2022

NPO-2270 ameliorates cardiac dysfunction more effectively than enalapril in models of HF

April 7, 2022

BETR-001 shows antidepressant activity in preclinical models

April 7, 2022

FDA clears IND for BiOneCure's anti-Trop-2 ADC, BIO-106

April 7, 2022

Novel series of glucosylceramide synthase inhibitors presented for treating Parkinson's disease

April 7, 2022

NPC1L1 gene polymorphisms tied to coronary artery calcification

April 7, 2022

ACE2-independent blood cell infection linked to severe COVID

April 6, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...